Hepatitis C virus infection in the elderly. Epidemiology, prophylaxis and optimal treatment.
Chronic infection with the hepatitis C virus (HCV) occurs throughout the world and appears to be the main cause of hepatocellular carcinoma. Studies have shown that, in areas of high endemicity, the prevalence of HCV infection is low in children but high in people aged > 60 years. Medical interventions were found to play an important role in the spread of HCV infection, because elderly patients became infected via contaminated blood transfusions or when contaminated syringes and needles were used. Maternal and sexual transmission do not appear to be the main routes of HCV infection. Interferon treatment eliminates HCV in 20 to 30% of patients with chronic HCV infection. The response to interferon therapy is usually complete in 70 to 80% of people with low levels of HCV RNA, HCV of genotype 2 and young women, but poor in elderly patients. Because liver disease can be severe in elderly patients, more effective therapies are clearly needed.
Hayashi
J
J
Department of General Medicine, Kyushu University Hospital, Fukuoka, Japan.
Kashiwagi
S
S
D000368:Aged; D015415:Biomarkers; D002908:Chronic Disease; D006526:Hepatitis C / Q000188:drug therapy / Q000453:epidemiology / Q000235:genetics / Q000276:immunology / Q000517:prevention & control; D018937:Hepatitis C Antibodies / Q000032:analysis; D006801:Humans; D007564:Japan / Q000453:epidemiology; D015995:Prevalence; D012367:RNA, Viral
D015415:Biomarkers; D018937:Hepatitis C Antibodies; D012367:RNA, Viral